1. Home
  2. APPN vs LMAT Comparison

APPN vs LMAT Comparison

Compare APPN & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APPN
  • LMAT
  • Stock Information
  • Founded
  • APPN 1999
  • LMAT 1983
  • Country
  • APPN United States
  • LMAT United States
  • Employees
  • APPN N/A
  • LMAT N/A
  • Industry
  • APPN Computer Software: Prepackaged Software
  • LMAT Medical/Dental Instruments
  • Sector
  • APPN Technology
  • LMAT Health Care
  • Exchange
  • APPN Nasdaq
  • LMAT Nasdaq
  • Market Cap
  • APPN 2.0B
  • LMAT 1.9B
  • IPO Year
  • APPN 2017
  • LMAT 2006
  • Fundamental
  • Price
  • APPN $30.80
  • LMAT $92.37
  • Analyst Decision
  • APPN Hold
  • LMAT Buy
  • Analyst Count
  • APPN 6
  • LMAT 6
  • Target Price
  • APPN $34.40
  • LMAT $99.67
  • AVG Volume (30 Days)
  • APPN 829.9K
  • LMAT 167.8K
  • Earning Date
  • APPN 11-06-2025
  • LMAT 10-30-2025
  • Dividend Yield
  • APPN N/A
  • LMAT 0.87%
  • EPS Growth
  • APPN N/A
  • LMAT 22.69
  • EPS
  • APPN N/A
  • LMAT 2.05
  • Revenue
  • APPN $657,803,000.00
  • LMAT $234,639,000.00
  • Revenue This Year
  • APPN $15.42
  • LMAT $16.32
  • Revenue Next Year
  • APPN $11.07
  • LMAT $8.62
  • P/E Ratio
  • APPN N/A
  • LMAT $45.09
  • Revenue Growth
  • APPN 13.67
  • LMAT 14.11
  • 52 Week Low
  • APPN $24.00
  • LMAT $71.42
  • 52 Week High
  • APPN $43.33
  • LMAT $109.58
  • Technical
  • Relative Strength Index (RSI)
  • APPN 53.06
  • LMAT 46.63
  • Support Level
  • APPN $29.40
  • LMAT $91.82
  • Resistance Level
  • APPN $31.60
  • LMAT $98.93
  • Average True Range (ATR)
  • APPN 1.02
  • LMAT 3.02
  • MACD
  • APPN 0.04
  • LMAT -0.90
  • Stochastic Oscillator
  • APPN 52.45
  • LMAT 32.23

About APPN Appian Corporation

Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its business in the United States.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.

Share on Social Networks: